Management of osteoporosis in Hong Kong.
Osteoporosis is among the top 3 medical conditions that are associated with greatest morbidity and reduction of quality of life of Hong Kong elderly subjects. The genetic and environmental risk factors for osteoporosis in southern Chinese as well as the current approach towards managing this growing health problem in Hong Kong are presented.
Kung
Annie W C
AW
Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
D015519:Bone Density; D002136:Calcium, Dietary / Q000008:administration & dosage; D003362:Cost-Benefit Analysis; D015914:Estrogen Replacement Therapy; D006266:Health Education; D006723:Hong Kong / Q000453:epidemiology; D006801:Humans; D008019:Life Style; D010024:Osteoporosis / Q000191:economics / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D010281:Parathyroid Hormone; D011322:Primary Prevention; D011788:Quality of Life; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D014807:Vitamin D / Q000627:therapeutic use
D002136:Calcium, Dietary; D010281:Parathyroid Hormone; D020845:Selective Estrogen Receptor Modulators; D014807:Vitamin D; D020849:Raloxifene Hydrochloride